Skip to main content

Table 2 Basic characteristics between 5-ARIs User and comparison groups with Upper Tract Urothelial Carcinoma (n = 1199)

From: 5α-reductase inhibitors impact prognosis of urothelial carcinoma

  5-ARIs User, n (%) None User, n (%) P-value
Case No. 109 1090  
Variables
 Age (Mean ± SD) 75.42 (±7.56) 75.75 (±7.62) 0.668
Age category (n, %)
 < 65 5 (4.59) 87 (7.98)  
 65–74 44 (40.37) 366 (33.58)  
 > 75 60 (55.05) 637 (58.44)  
 CCI score (Mean ± SD) 4.84 (±2.55) 4.68 (±2.40) 0.501
CCI score category
 0 ~ 3 38 (34.86) 390 (35.78)  
 4 ~ 7 55 (50.46) 547 (50.18)  
 8+ 16 (14.68) 153 (14.04)  
Comorbidity
 Hypertension 57 (52.29) 553 (50.73) 0.756
 Hyperlipidemia 24 (22.02) 227 (20.83) 0.770
 Diabetes mellitus 31 (28.44) 292 (26.79) 0.711
 Chronic Kidney Disease 17 (15.60) 169 (15.50) 0.980
  1. CCI Charlson Comorbidity Index